I'm hoping for a strategic partnership and a return of some capital to shareholders.
Don't want to be a broken record but:
UNS needs 150MM (111MM on the razor edge) in capital to comfortably get to production. Griffin pegs them making .70 cents per share by 2020 only with lovenox, Himma, and very few WI's in their projections which suggests they could be a very profitable company should AbbVie and the other various projects come to fruition.
Sell part of the company return some capital to shareholders so it won't be totally dilutive and move on.
Add to My Watchlist
What is My Watchlist?